Back

LCZ696 and the use of biomarkers.

22 May 2016 (17:08 - 17:21)
Organised by:
Congress Presentation Part of: What a busy clinician needs to know about LCZ696 for heart failure Miscellaneous HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
The drug and the PARADIGM-HF trial.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
What was it approved for in Europe – The EMA recommendations.
Doctor K. Prasad (London, GB)
Slides Video
Presentation thumbnail
What the 2016 guidelines say.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
LCZ696 and Alzheimers?
Professor A. Zeiher (Frankfurt, DE)
Slides Video
Presentation thumbnail
LCZ696 and drug-drug interactions?
Professor G. Rosano (London, GB)

Access the full session

Session thumbnail
What a busy clinician needs to know about LCZ696 for heart failure

The Event

Event poster

HEART FAILURE 2016

22 May 2016 17:08 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources